Time | Clinical remission | Low-level group(n = 52) | High-level group(n = 42) | P value |
---|---|---|---|---|
6Â months | CR, n (%) | 5 (9.6%) | 0 (0%) | 0.047 |
PR, n (%) | 22 (42.3%) | 8 (19%) | 0.140 | |
TR, n (%) | 27 (51.9%) | 8 (19%) | 0.001 | |
NR, n (%) | 25 (48.1%) | 34 (81%) |  0.001 | |
12 months | CR, n (%) | 22 (42.3%) | 2 (4.7%) | < 0.001 |
PR, n (%) | 21 (40.4%) | 14 (33.3%) | 0.313 | |
TR, n (%) | 43 (82.7%) | 16 (38%) | < 0.001 | |
NR, n (%) | 9 (17.3%) | 26 (62%) | < 0.001 | |
18 months | CR, n (%) | 27 (51.9%) | 6 (14.3%) | < 0.001 |
PR, n (%) | 19 (36.6%) | 12 (28.6%) | 0.276 | |
TR, n (%) | 46 (88.5%) | 18 (42.9%) | < 0.001 | |
NR, n (%) | 6 (11.5%) | 24 (57.1%) | < 0.001 | |
24Â months | CR, n (%) | 27 (51.9%) | 9 (21.45%) | 0.002 |
PR, n (%) | 19 (36.6%) | 9 (21.45%) | 0.085 | |
TR, n (%) | 46 (88.5%) | 18 (42.9%) | < 0.001 | |
NR, n (%) | 6 (11.5%) | 24 (57.1%) | < 0.001 |